These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29925999)

  • 1. High Baseline Lipoprotein(a) Level as a Risk Factor for Coronary Artery Calcification Progression: Sub-analysis of a Prospective Multicenter Trial.
    Ida J; Kotani K; Miyoshi T; Nakamura K; Kohno K; Asonuma H; Sakuragi S; Doi M; Miki T; Koyama Y; Ito H
    Acta Med Okayama; 2018 Jun; 72(3):223-230. PubMed ID: 29925999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of coronary artery calcification progression in subjects with high baseline Lp(a) levels: The Kangbuk Samsung Health Study.
    Cho JH; Lee DY; Lee ES; Kim J; Park SE; Park CY; Lee WY; Oh KW; Park SW; Rhee EJ
    Int J Cardiol; 2016 Nov; 222():233-237. PubMed ID: 27497100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors.
    Ong KL; McClelland RL; Allison MA; Cushman M; Garg PK; Tsai MY; Rye KA; Tabet F
    Metabolism; 2021 Mar; 116():154706. PubMed ID: 33421505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein (a) is independently correlated with coronary artery calcification.
    Greif M; Arnoldt T; von Ziegler F; Ruemmler J; Becker C; Wakili R; D'Anastasi M; Schenzle J; Leber AW; Becker A
    Eur J Intern Med; 2013 Jan; 24(1):75-9. PubMed ID: 23021791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Intensive and Standard Pitavastatin Treatment With or Without Eicosapentaenoic Acid on Progression of Coronary Artery Calcification Over 12 Months - Prospective Multicenter Study.
    Miyoshi T; Kohno K; Asonuma H; Sakuragi S; Nakahama M; Kawai Y; Uesugi T; Oka T; Munemasa M; Takahashi N; Mukohara N; Habara S; Koyama Y; Nakamura K; Ito H;
    Circ J; 2018 Jan; 82(2):532-540. PubMed ID: 28867681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in oxidized high-density lipoprotein is associated with slowed progression of coronary artery calcification: Subanalysis of a prospective multicenter study.
    Miki T; Miyoshi T; Kotani K; Kohno K; Asonuma H; Sakuragi S; Koyama Y; Nakamura K; Ito H
    Atherosclerosis; 2019 Apr; 283():1-6. PubMed ID: 30769272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.
    Malluche HH; Blomquist G; Monier-Faugere MC; Cantor TL; Davenport DL
    J Am Soc Nephrol; 2015 Oct; 26(10):2534-44. PubMed ID: 25838468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein (a) and risk for calcification of the coronary arteries, mitral valve, and thoracic aorta: The Multi-Ethnic Study of Atherosclerosis.
    Garg PK; Guan W; Karger AB; Steffen BT; Budoff M; Tsai MY
    J Cardiovasc Comput Tomogr; 2021; 15(2):154-160. PubMed ID: 32620506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of lipoprotein(a) and coronary artery calcium in asymptomatic patients: a systematic review and meta-analysis.
    Martignoni FV; Rl Júnior JE; Marques IR; Gomes C; Moreira VCS; de Souza IAF; Miyawaki IA; Silva CH; do Amaral Neto AB; Padrão EMH; Cardoso R; de Vasconcellos HD; Miedema M
    Eur J Prev Cardiol; 2024 Apr; 31(6):732-741. PubMed ID: 38300625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification.
    Pechlivanis S; Mahabadi AA; Hoffmann P; Nöthen MM; Broecker-Preuss M; Erbel R; Moebus S; Stang A; Jöckel KH
    BMC Med Genet; 2020 Mar; 21(1):62. PubMed ID: 32220223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.
    Alonso R; Mata P; Muñiz O; Fuentes-Jimenez F; Díaz JL; Zambón D; Tomás M; Martin C; Moyon T; Croyal M; Thedrez A; Lambert G
    Atherosclerosis; 2016 Nov; 254():249-253. PubMed ID: 27594539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related contribution of Lp(a) with coronary artery calcification in patients with acute coronary syndrome: a potential role of metabolic disorder in calcified plaque.
    Ryu SK; Hong BK; Kwon HM; Kim DS; Chung WJ; Park BE; Kim DY; Cho YH; Yoon SJ; Yoon YW; Cho SY; Kim HS
    Yonsei Med J; 2003 Jun; 44(3):445-53. PubMed ID: 12833582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The number of circulating CD34-positive cells is an independent predictor of coronary artery calcification progression: Sub-analysis of a prospective multicenter study.
    Ichikawa K; Miyoshi T; Osawa K; Miki T; Kohno K; Nakamura K; Koyama Y; Ito H
    Cardiol J; 2022; 29(3):423-431. PubMed ID: 34787888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein (a), metabolic syndrome and coronary calcium score in a large occupational cohort.
    Sung KC; Wild SH; Byrne CD
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1239-46. PubMed ID: 23786824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of lipoprotein(a) in coronary artery calcification among asymptomatic cardiovascular disease subjects: A systematic review and meta-analysis.
    Vazirian F; Sadeghi M; Kelesidis T; Budoff MJ; Zandi Z; Samadi S; Mohammadpour AH
    Nutr Metab Cardiovasc Dis; 2023 Nov; 33(11):2055-2066. PubMed ID: 37567791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between lipoprotein(a) and coronary artery calcification in the Genetic Epidemiology Network of Arteriopathy (GENOA) study.
    Kullo IJ; Bailey KR; Bielak LF; Sheedy PF; Klee GG; Kardia SL; Peyser PA; Boerwinkle E; Turner ST
    Mayo Clin Proc; 2004 Oct; 79(10):1258-63. PubMed ID: 15473406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of lipoprotein (a) with coronary artery calcification: A systematic review and meta-analysis.
    Qiu Y; Hao W; Guo Y; Guo Q; Zhang Y; Liu X; Wang X; Nie S
    Atherosclerosis; 2024 Jan; 388():117405. PubMed ID: 38101270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.
    Erbel R; Lehmann N; Churzidse S; Möhlenkamp S; Moebus S; Mahabadi AA; Schmermund A; Stang A; Dragano N; Grönemeyer D; Seibel R; Kälsch H; Bauer M; Bröcker-Preuss M; Mann K; Jöckel KH;
    Atherosclerosis; 2013 Aug; 229(2):531-40. PubMed ID: 23701995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary calcification is associated with elevated serum lipoprotein (a) levels in asymptomatic men over the age of 45 years: A cross-sectional study of the Korean national health checkup data.
    Chung YH; Lee BK; Kwon HM; Min PK; Choi EY; Yoon YW; Hong BK; Rim SJ; Kim JY
    Medicine (Baltimore); 2021 Mar; 100(9):e24962. PubMed ID: 33655963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipokines and severity and progression of coronary artery calcium: Findings from the Rancho Bernardo Study.
    Larsen BA; Laughlin GA; Cummins K; Barrett-Connor E; Wassel CL
    Atherosclerosis; 2017 Oct; 265():1-6. PubMed ID: 28825974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.